Seroprevalence of Hepatitis B Infection in Nigeria: A National Survey
2016/08/16 by Adebola T. Olayinka, Adebola Olayinka, Akin Oyemakinde +12 · 26 citations
Medicine · #Hepatitis B Virus Studies #Hepatitis C virus research #Hepatitis Viruses Studies and Epidemiology
paper · pdf · doi:10.4269/ajtmh.15-0874
Abstract
Hepatitis B virus (HBV) infection accounts for about 1 million deaths worldwide annually. This study was to determine the prevalence, distribution of HBV, and factors associated with infection in an apparently healthy population in Nigeria. A cross-sectional study among the general population was conducted employing a multistage sampling technique. Data on demographic, social, and behavioral indicators were collected using questionnaires and blood samples tested for HBV seromarkers. Descriptive, bivariate, and multivariate analyses were done. Prevalence of hepatitis B infection was 12.2% (confidence interval [CI] = 10.3-14.5). Of the participants, more than half, 527 (54.6%), had evidence of previous exposure to HBV, while 306 (31.7%) showed no serologic evidence of infection or vaccination. Only 76 (7.9%) participants showed serologic evidence of immunity to HBV through vaccination. Factors associated with testing positive for HBV infection were dental procedure outside the health facility (odds ratios [OR] = 3.4, 95% CI = 1.52-7.70), local circumcision (OR = 1.73, 95% CI = 1.17-2.57), and uvulectomy (OR = 1.65, 95% CI = 1.06-2.57). With logistic regression, only dental procedure outside the health facility (adjusted OR = 3.32, 95% CI = 1.38-7.97) remained significant. This first national survey on seroprevalence of hepatitis B describes the epidemiology and high prevalence of HBV infection in Nigeria and highlights the need for improved vaccination against HBV.
Cited by
- Hyperendemicity and genotype diversity of hepatitis B virus among patients attending the University of Abuja Teaching Hospital, Nigeria
- Seroprevalence of Hepatitis B Virus and Compliance to Standard Safety Precautions among Scavengers in Ilorin Metropolis, Kwara State, Nigeria. [europepmc]
- Epidemiology of HBV in Pregnant Women, South West Nigeria. [europepmc]
- Determinants of Timely Presentation for Birth Dose Vaccination at an Immunization Centre in North-central Nigeria. [europepmc]
- Pattern of prevalent Hepatitis B virus genotypes in Zaria, Nigeria. [europepmc]
- Does voluntary medical male circumcision protect against sexually transmitted infections among men and women in real-world scale-up settings? Findings of a household survey in KwaZulu-Natal, South Africa. [europepmc]
- Blood donors deferral prevalence and causes in a tertiary health care hospital, southern Nigeria. [europepmc]
- Seroprevalence of hepatitis B virus among antenatal clinic attendees in Gamawa Local Government Area, Bauchi State, Nigeria. [europepmc]
- Data on information sources, knowledge and practice on hepatitis B virus in southwest Nigeria. [europepmc]
- Prevalence, seroconversion and mother-to-child transmission of dual and triplex infections of HIV, hepatitis B and C viruses among pregnant women in Nigeria: study protocol. [europepmc]
- Hepatitis B infection and risk factors among pregnant women and their male partners in the Baby Shower Programme in Nigeria: a cross-sectional study. [europepmc]
- Screening, Vaccination, and Referrals as Viral Hepatitis Elimination Triad Among Internally Displaced Persons in Edo State, Nigeria. [europepmc]
- Studies on the serological markers for hepatitis B virus infection among type 2 diabetic patients. [europepmc]
- Prevalence and factors associated with hepatitis B virus infection among household members: a cross-sectional study in Beijing. [europepmc]
- Serological markers and risk factors associated with Hepatitis B virus infection among Federal Capital Territory prison inmates, Nigeria: Should we be concerned? [europepmc]
- Detection of Q129H Immune Escape Mutation in Apparently Healthy Hepatitis B Virus Carriers in Southwestern Nigeria. [europepmc]
- Knowledge, attitude and occupational risks to hepatitis B infection among health workers in Gulu Regional Referral Hospital, Northern Uganda: a cross-sectional study design. [europepmc]
- A systematic review and meta-analysis of the prevalence of hepatitis B virus infection among pregnant women in Nigeria. [europepmc]
- Hepatitis B virus infection in Nigeria: a systematic review and meta-analysis of data published between 2010 and 2019. [europepmc]
- Prevalence of hepatitis B virus core antibodies among blood donors in Nigeria: Implications for blood safety. [europepmc]
- A Review with Updated Perspectives on the Antiviral Potentials of Traditional Medicinal Plants and Their Prospects in Antiviral Therapy. [europepmc]
- Molecular detection of hepatitis B virus genotype E with immune escape mutations in chronic hepatitis B patients on long-term antiviral therapy in Jos, Nigeria. [europepmc]
- Patterns of hepatitis b virus immune escape and pol/rt mutations across clinical cohorts of patients with genotypes a, e and occult hepatitis b infection in Nigeria: A multi-centre study. [europepmc]
- Evaluation of a school-based health education program on hepatitis B virus infection prevention practice in rural South-Western, Nigeria. [europepmc]
- Non-invasive assessment of hepatic fibrosis among patients with chronic hepatitis B virus infection in three tertiary hospitals in Nigeria. [europepmc]
- The interplay of socio-demographic factors and disease prevalence: insights into malaria, Hepatitis B, and Hepatitis C in Lafia, Nasarawa State, Nigeria. [europepmc]
Related